Asahi Intecc Co., Ltd.

TSE:7747 Stock Report

Market Cap: JP¥711.8b

Asahi Intecc Valuation

Is 7747 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7747 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7747 (¥2620.5) is trading above our estimate of fair value (¥1811.36)

Significantly Below Fair Value: 7747 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7747?

Key metric: As 7747 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7747. This is calculated by dividing 7747's market cap by their current earnings.
What is 7747's PE Ratio?
PE Ratio43.1x
EarningsJP¥16.52b
Market CapJP¥711.79b

Price to Earnings Ratio vs Peers

How does 7747's PE Ratio compare to its peers?

The above table shows the PE ratio for 7747 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average64.7x
8086 Nipro
173.5x24.6%JP¥226.7b
7730 Mani
27.3x9.2%JP¥171.6b
7780 Menicon
24.1x19.4%JP¥116.7b
3593 Hogy MedicalLtd
33.8x9.5%JP¥99.3b
7747 Asahi Intecc
43.1x12.2%JP¥711.8b

Price-To-Earnings vs Peers: 7747 is good value based on its Price-To-Earnings Ratio (43.1x) compared to the peer average (64.7x).

Price to Earnings Ratio vs Industry

How does 7747's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
7747 43.1xIndustry Avg. 15.6xNo. of Companies6PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7747 is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the JP Medical Equipment industry average (15.6x).

Price to Earnings Ratio vs Fair Ratio

What is 7747's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7747 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43.1x
Fair PE Ratio25.2x

Price-To-Earnings vs Fair Ratio: 7747 is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the estimated Fair Price-To-Earnings Ratio (25.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7747 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,620.50
JP¥3,332.67
+27.2%
11.8%JP¥4,200.00JP¥2,600.00n/a15
Nov ’25JP¥2,433.00
JP¥3,270.71
+34.4%
13.4%JP¥4,000.00JP¥2,440.00n/a14
Oct ’25JP¥2,533.50
JP¥3,270.71
+29.1%
13.4%JP¥4,000.00JP¥2,440.00n/a14
Sep ’25JP¥2,670.50
JP¥3,210.00
+20.2%
13.3%JP¥4,000.00JP¥2,440.00n/a14
Aug ’25JP¥2,270.00
JP¥3,246.15
+43.0%
14.9%JP¥4,000.00JP¥2,220.00n/a13
Jul ’25JP¥2,180.50
JP¥3,261.54
+49.6%
14.6%JP¥3,800.00JP¥2,220.00n/a13
Jun ’25JP¥2,262.00
JP¥3,278.57
+44.9%
14.2%JP¥3,800.00JP¥2,220.00n/a14
May ’25JP¥2,321.00
JP¥3,395.71
+46.3%
10.6%JP¥3,800.00JP¥2,400.00n/a14
Apr ’25JP¥2,591.00
JP¥3,424.29
+32.2%
7.9%JP¥3,800.00JP¥2,800.00n/a14
Mar ’25JP¥3,111.00
JP¥3,403.08
+9.4%
7.9%JP¥3,800.00JP¥2,800.00n/a13
Feb ’25JP¥2,844.50
JP¥3,320.77
+16.7%
9.0%JP¥3,730.00JP¥2,600.00n/a13
Jan ’25JP¥2,868.50
JP¥3,320.77
+15.8%
9.0%JP¥3,730.00JP¥2,600.00n/a13
Dec ’24JP¥2,831.00
JP¥3,347.86
+18.3%
9.1%JP¥3,730.00JP¥2,600.00n/a14
Nov ’24JP¥2,531.00
JP¥3,317.69
+31.1%
9.6%JP¥3,700.00JP¥2,500.00JP¥2,433.0013
Oct ’24JP¥2,688.00
JP¥3,407.00
+26.7%
6.9%JP¥3,700.00JP¥2,800.00JP¥2,533.5010
Sep ’24JP¥2,921.50
JP¥3,277.00
+12.2%
9.4%JP¥3,600.00JP¥2,600.00JP¥2,670.5010
Aug ’24JP¥2,950.00
JP¥3,305.00
+12.0%
10.0%JP¥3,600.00JP¥2,600.00JP¥2,270.0010
Jul ’24JP¥2,811.00
JP¥3,215.00
+14.4%
11.5%JP¥3,600.00JP¥2,600.00JP¥2,180.5010
Jun ’24JP¥2,732.00
JP¥3,118.18
+14.1%
12.5%JP¥3,600.00JP¥2,550.00JP¥2,262.0011
May ’24JP¥2,484.00
JP¥2,986.36
+20.2%
13.0%JP¥3,500.00JP¥2,300.00JP¥2,321.0011
Apr ’24JP¥2,324.00
JP¥2,979.17
+28.2%
12.5%JP¥3,500.00JP¥2,300.00JP¥2,591.0012
Mar ’24JP¥2,237.00
JP¥3,004.17
+34.3%
12.6%JP¥3,500.00JP¥2,300.00JP¥3,111.0012
Feb ’24JP¥2,239.00
JP¥3,020.83
+34.9%
11.8%JP¥3,500.00JP¥2,300.00JP¥2,844.5012
Jan ’24JP¥2,164.00
JP¥3,070.83
+41.9%
14.1%JP¥4,000.00JP¥2,300.00JP¥2,868.5012
Dec ’23JP¥2,530.00
JP¥3,045.83
+20.4%
14.4%JP¥4,000.00JP¥2,300.00JP¥2,831.0012
Nov ’23JP¥2,513.00
JP¥3,029.17
+20.5%
14.0%JP¥4,000.00JP¥2,300.00JP¥2,531.0012

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

FINDEX

JP¥20.5b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

7D

-0.7%

1Y

-12.5%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,936.00

7D

-2.8%

1Y

-1.8%

Saint-Care Holding

JP¥18.1b

Provides healthcare services in Japan.

2374

JP¥735.00

7D

2.8%

1Y

-21.4%